Gene Therapy Shows Promise in Partially Restoring Sight in Blind Patients
Audio narration · Coming soon
Researchers have revealed that optogenetic therapy, which uses light to control nerve cells, can partially restore sight in blind individuals. This approach is based on Nobel prize-winning science and represents a significant advancement in gene therapy applications for vision restoration.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews